NL8203057A - Farmaceutische excipientia. - Google Patents

Farmaceutische excipientia. Download PDF

Info

Publication number
NL8203057A
NL8203057A NL8203057A NL8203057A NL8203057A NL 8203057 A NL8203057 A NL 8203057A NL 8203057 A NL8203057 A NL 8203057A NL 8203057 A NL8203057 A NL 8203057A NL 8203057 A NL8203057 A NL 8203057A
Authority
NL
Netherlands
Prior art keywords
excipient
active ingredient
tablets
pharmaceutical preparation
coating
Prior art date
Application number
NL8203057A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8203057A publication Critical patent/NL8203057A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
NL8203057A 1981-08-05 1982-07-30 Farmaceutische excipientia. NL8203057A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23374/81A IT1168014B (it) 1981-08-05 1981-08-05 Forme farmaceutiche a cessione protratta
IT2337481 1981-08-05

Publications (1)

Publication Number Publication Date
NL8203057A true NL8203057A (nl) 1983-03-01

Family

ID=11206523

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8203057A NL8203057A (nl) 1981-08-05 1982-07-30 Farmaceutische excipientia.

Country Status (18)

Country Link
US (1) US4499066A (hu)
JP (1) JPS5829717A (hu)
AT (1) AT381639B (hu)
AU (1) AU557693B2 (hu)
BE (1) BE894028A (hu)
CA (1) CA1217721A (hu)
CH (1) CH657046A5 (hu)
DE (1) DE3228999A1 (hu)
DK (1) DK161182C (hu)
FI (1) FI822683L (hu)
FR (1) FR2510888B1 (hu)
GB (1) GB2107214B (hu)
IE (1) IE53614B1 (hu)
IL (1) IL66435A0 (hu)
IT (1) IT1168014B (hu)
NL (1) NL8203057A (hu)
SE (1) SE454325B (hu)
ZA (1) ZA825553B (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2141023B (en) * 1983-06-06 1986-09-03 Robins Co Inc A H Delayed release formulations
IE56459B1 (en) * 1983-12-21 1991-08-14 Elan Corp Ltd Controlled absorption pharmaceutical formulation
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4894240A (en) * 1983-12-22 1990-01-16 Elan Corporation Plc Controlled absorption diltiazem formulation for once-daily administration
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
US4917899A (en) * 1983-12-22 1990-04-17 Elan Corporation Plc Controlled absorption diltiazem formulation
EP0147780A3 (en) * 1984-01-03 1987-03-11 Merck & Co. Inc. Drug delivery device
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
FR2576213B1 (fr) * 1985-01-21 1989-02-24 Cortial Nouveau procede d'obtention de formes pharmaceutiques a liberation prolongee
JPS61236723A (ja) * 1985-04-12 1986-10-22 Fujimoto Seiyaku Kk 持続性ニフエジピン坐剤
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
US4990335A (en) * 1987-03-25 1991-02-05 E. I. Du Pont De Nemours And Company Use of vinyl alcohol homopolymer and copolymers for tableting active materials
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
NZ224252A (en) * 1987-04-21 1991-09-25 Erba Carlo Spa An anthracycline glycoside and its preparation
CA1334379C (en) * 1987-11-24 1995-02-14 James William Mcginity Method for preparing a solid sustained release form of a functionally active composition
US5051261A (en) * 1987-11-24 1991-09-24 Fmc Corporation Method for preparing a solid sustained release form of a functionally active composition
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
DE60128215T2 (de) 2000-04-20 2008-01-10 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
GB0507695D0 (en) * 2005-04-15 2005-05-25 Novartis Ag Organic compounds
US20060287212A1 (en) * 2005-06-02 2006-12-21 Novozymes A/S Blends of inactive particles and active particles
JP2008545841A (ja) 2005-06-02 2008-12-18 ノボザイムス アクティーゼルスカブ 不活性粒子及び活性粒子のブレンド

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US27107A (en) * 1860-02-14 Improvement in cotten-seed planters
US2996431A (en) * 1953-12-16 1961-08-15 Barry Richard Henry Friable tablet and process for manufacturing same
BE564759A (hu) * 1955-12-22
US3402240A (en) * 1957-06-25 1968-09-17 Pfizer & Co C Medicinal tablet and process of making same
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3115441A (en) * 1962-06-06 1963-12-24 Victor M Hermelin Timed release pharmaceutical preparations and method of making the same
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
USRE27107E (en) 1968-05-01 1971-03-30 Drug composition
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
US3908003A (en) * 1971-07-02 1975-09-23 American Home Prod Enrobed solid hydrophobic tableting lubricants and compositions
FI63335B (fi) * 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4361545A (en) * 1979-05-21 1982-11-30 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
US4308251A (en) * 1980-01-11 1981-12-29 Boots Pharmaceuticals, Inc. Controlled release formulations of orally-active medicaments

Also Published As

Publication number Publication date
IT1168014B (it) 1987-05-20
ZA825553B (en) 1983-06-29
IE821861L (en) 1983-02-05
IL66435A0 (en) 1982-12-31
JPS5829717A (ja) 1983-02-22
GB2107214A (en) 1983-04-27
BE894028A (fr) 1983-02-04
AU8660682A (en) 1983-02-10
CA1217721A (en) 1987-02-10
IT8123374A0 (it) 1981-08-05
AT381639B (de) 1986-11-10
AU557693B2 (en) 1987-01-08
US4499066A (en) 1985-02-12
CH657046A5 (de) 1986-08-15
DE3228999C2 (hu) 1991-06-27
DK161182B (da) 1991-06-10
SE454325B (sv) 1988-04-25
ATA295082A (de) 1986-04-15
GB2107214B (en) 1985-04-24
JPH0116808B2 (hu) 1989-03-27
FI822683L (fi) 1983-02-06
DE3228999A1 (de) 1983-02-24
FR2510888B1 (fr) 1986-03-21
FR2510888A1 (fr) 1983-02-11
SE8204581D0 (sv) 1982-08-04
IE53614B1 (en) 1988-12-21
DK345682A (da) 1983-02-06
FI822683A0 (fi) 1982-08-02
DK161182C (da) 1991-11-25
SE8204581L (sv) 1983-02-06

Similar Documents

Publication Publication Date Title
NL8203057A (nl) Farmaceutische excipientia.
Verma et al. Development and evaluation of osmotically controlled oral drug delivery system of glipizide
Karasulu et al. Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates
CA2217226C (en) Controlled release formulation for water soluble drugs in which a passageway is formed in situ
Kumaravelrajan et al. Development and evaluation of controlled porosity osmotic pump for Nifedipine and Metoprolol combination
CZ73196A3 (en) Novel balls for controlled release and pharmaceutical preparation in which said balls are contained
US20060088594A1 (en) Highly compressible controlled delivery compositions of metformin
JP2008508227A (ja) 高ｐｈ依存性溶解度を有する有効成分の放出制御のための医薬品多層錠剤
JPH07277957A (ja) 新規な拡散−浸透の制御の薬−放出性の製薬学的組成物及びその製法
JP2002275053A (ja) 医薬錠剤及びその製造のための方法
Rao et al. Review on Matrix Tablet as Sustained Release.
JPH0625055B2 (ja) 持続性錠剤
CA2613357A1 (en) Semi-permeable compositions providing reduced drying time for osmotic dosage forms
WO2021096444A1 (en) Pharmaceutical compositions comprising ticagrelor
WO2008044111A1 (en) Pharmaceutical formulation tablet
Phaechamud et al. Double-layered matrix of shellac wax-lutrol in controlled dual drug release
EP3024443A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
CN113811294B (zh) 用于治疗或预防高血压和高脂血症的单一剂型药物组合物
Draganoiu Evaluation of Kollidon SR for pH-independent extended release matrix systems
Obeidat et al. Investigations on Compaction Behavior of Kollidon® SR-Based Multi-component Directly Compressed Tablets for Preparation of Controlled Release Diclofenac Sodium
Nirmala et al. Development and in vivo evaluation of nelfinavir extended release trilayer matrix tablets in the management of AIDS
AGIBA et al. Modulatory effect of polymer type and concentration on drug release from sustained release matrix tablets of ranolazine: a comparative release kinetic study
McCall et al. TIMERx oral controlled-release drug delivery system
Wadurkar et al. A REVIEW ON MODIFIED RELEASE DOSAGE FORM AND DRUG DELIVERY SYSTEM
Chang Design and Optimization of Nanoparticulate Permeability-Modifiers for pH-independent Drug Release and Alcohol-resistant Dosage Forms

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed